Thank you for writing to us. One of our executive will reach back to you through your submitted medium. In case there’s an urgency, feel free to connect over WhatsApp for faster response.
Prefer calling? Dial +9108209542042 (International callers) or +9108209542042 (Indian callers).
R.S. IPRATROP 1.25 is a combination respiratory solution formulated with Levosalbutamol and Ipratropium Bromide, specifically designed for the management of chronic respiratory conditions such as asthma, chronic bronchitis, and Chronic Obstructive Pulmonary Disease (COPD).
Levosalbutamol is a short-acting beta2-agonist that works by relaxing airway muscles, providing rapid relief from bronchospasms. Ipratropium Bromide is an anticholinergic bronchodilator that prevents airway constriction and reduces mucus secretion. Together, they provide fast-acting and sustained relief from breathing difficulties, ensuring better airflow and lung function.
This respiratory solution is nebuliser-friendly, delivering medication directly to the lungs for optimal efficacy and faster symptom relief.
Uses
R.S. IPRATROP 1.25 is indicated for:
Relief and management of bronchospasms in asthma and COPD.
Treatment of chronic bronchitis with airflow obstruction.
Control of wheezing, coughing, and shortness of breath.
Improving lung function in patients with obstructive respiratory conditions.
Management of acute exacerbations and prevention of severe breathing episodes.
By combining a bronchodilator and an anticholinergic agent, it addresses both immediate symptoms and long-term airway management.
Benefits
Dual-Action Therapy: Combines fast-acting Levosalbutamol with long-lasting Ipratropium Bromide for comprehensive symptom relief.
Rapid Symptom Relief: Quickly alleviates wheezing, chest tightness, and shortness of breath.
Improves Airflow: Relaxes airway muscles and prevents bronchial constriction.
Reduces Mucus Production: Helps clear airways for easier breathing.
Nebuliser Compatible: Ensures direct delivery to the lungs for faster and effective results.
Supports Daily Activities: Helps patients maintain normal routines with improved respiratory health.
Dosage
Adults: Typically, 1–2 nebuliser doses 2–3 times daily, or as directed by a healthcare professional.
Children: Dosage must be determined by a pediatrician according to age and severity of symptoms.
Administer using a nebuliser, inhaling slowly and deeply until the full dose is delivered.
Follow the prescribed schedule strictly; do not alter doses without consulting your doctor.
Do not use as a substitute for emergency rescue medication during sudden asthma attacks.
Side Effects
Common side effects may include:
Throat irritation or dryness
Mild cough or sneezing
Headache or dizziness
Tremors or palpitations
Serious side effects are rare but may include rapid heartbeat, allergic reactions, or worsening breathing. Seek immediate medical attention if severe reactions occur.
Precautions and Warning
Pregnancy & Breastfeeding: Only use under medical supervision.
Heart Conditions: Consult a doctor if you have arrhythmia, hypertension, or cardiovascular disease.
Glaucoma & Prostate Disorders: Use caution, as Ipratropium may worsen symptoms.
Allergies: Avoid if allergic to Levosalbutamol, Ipratropium Bromide, or any excipients.
Storage: Store in a cool, dry place below 30°C, away from sunlight, and out of children’s reach.
Not for Acute Attacks Alone: Keep a rescue inhaler for sudden breathing difficulties.
Conclusion
R.S. IPRATROP 1.25 (Levosalbutamol & Ipratropium Bromide Respiratory Solution) is a clinically proven dual-action therapy for effective management of asthma, COPD, and chronic bronchitis. By combining rapid bronchodilation with sustained airway relaxation, it provides fast relief, improves lung function, and prevents respiratory flare-ups.
